BHV-1400 clinical trials

Study of BHV-1400 in IgA Nephropathy

This study is testing a new medicine, BHV-1400, for IgA Nephropathy (IgAN). We want to find out if it's safe and if people can take it without too many problems. It's for adults aged 18-65 who have been diagnosed with IgAN.